TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.80
+0.79 (5.64%)
Oct 19, 2026, 4:00 PM EDT - Market closed
TRex Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
398.45M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 39.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
TRXB News
- 6 days ago - TRexBio Announces Closing of Initial Public Offering - GlobeNewsWire
- 7 days ago - Opening Day: Biotech duo Retension, TRex Bio come public - TheFly
- 10 days ago - TRex Bio opens at $13.50, IPO priced at $14 per share - TheFly
- 10 days ago - TRex Bio indicated to open at $13.90, IPO priced at $14 - TheFly
- 10 days ago - TRex Bio indicated to open at $14.05, IPO priced at $14 - TheFly
- 10 days ago - TRex Bio indicated to open at $14.50, IPO priced at $14 - TheFly
- 11 days ago - TRex Bio 8.333M share IPO priced at $14.00 - TheFly
- 11 days ago - TRexBio Announces Pricing of Initial Public Offering - GlobeNewsWire